Announcement on Wholly-owned Subsidiary Obtaining "Drug Registration Certificate" for Sitafloxacin Tablets

About this update from Zhejiang Ausun Pharmaceutical Co., Ltd. Class A

Announcement on Wholly-owned Subsidiary Obtaining "Drug Registration Certificate" for Sitafloxacin Tablets The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang Ausun Pharmaceutical Co., Ltd. Class A